Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA1912 LDC4297Summary: LDC4297 is a selective inhibitor. -
BA1913 TrilobatinSummary: Trilobatin is a sweetener derived from Rehd, Trilobatin is an inhibitor that targets the Gp41 envelope protein. -
BA1914 ZL0580Summary: ZL0580 is a structural analog of ZL0590 and induces epitope inhibition by selective binding to the structural domain of BD1. -
BA1915 FosamprenavirSummary: Fosamprenavir (Amprenavirphosphate; GW433908) is a phosphate precursor of the antiretroviral protease inhibitor Amprenavir with improved solubility. -
BA1916 DiphyllinSummary: Diphyllin, an arylnaphthalene lignan, is a potent inhibitor. -
BA1917 TrecovirsenSummary: An antisense oligonucleotide targeting the gag gene. -
BA1918 BevirimatSummary: Inhibitors of HIV-1 viral particle maturation. -
BA1919 RabdosiinSummary: Rabdosiin is a caffeic acid tetramer. -
BA1920 Apelin-12Summary: Apelin-12 is one of the most potent C-terminal fragments of the peptide with high affinity for the orphan receptor receptor. -
BA1921 TAK-220Summary: TAK-220 is a selective, orally available antagonist.

